Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.

S Suciu, Alexander M M Eggermont, Paul Lorigan, John M. Kirkwood, Svetomir N. Markovic, Claus Garbe, David Cameron, Srividya Kotapati, Tai-Tsang Chen, Keith Wheatley, Natalie Ives, Gaetan de Schaetzen, Achmad Efendi, Marc Buyse

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of the National Cancer Institute
Volume110
Issue number1
Early online date22 Aug 2017
DOIs
Publication statusPublished - 1 Jan 2018

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this